TITLE:
Hypertension Associated with Atherosclerosis Risk Factors in Patients of Family Health Strategy Highlighting the Framingham Risk Score
AUTHORS:
Bruna Lais da Silva Coutinho, Rosana Andrade Brito, Ana Isabel Cezário de Carvalho Conceição, Fabíola de Jesus Cardoso, Andreza Silva dos Santos, Bruno Felipe Ferreira Lopes, Rubson Dantas da Silva, Polyane Medeiros Alves, Raiane dos Santos Pereira, Álvaro Luís Müller da Fonseca
KEYWORDS:
Hypertension, Risk Factors, Atherosclerosis, Cardiovascular Diseases, Framingham Risk Score, Family Health Strategy
JOURNAL NAME:
Open Journal of Preventive Medicine,
Vol.8 No.8,
August
15,
2018
ABSTRACT: The Systemic Arterial Hypertension (SAH) stands out among the chronic non-transmissible pathologies that impact the cause and/or aggravation of cardiovascular diseases (CVD) on a global level, as the disease is an underestimated disorder due to non-perceptive symptoms and associated with factors and risk markers of another CVD. Therefore, establishing the risk of progression and aggravation of the SAH, according the Framingham Risk Score (FRS), allows to reducing morbidity and improving preventative measures for DCVs. This observational and transversal study approaches the data collection of patient records at the Health Family Strategy of Senhor do Bonfim, BA, which established differences by descriptive and inferential statistical analysis (correlation and regression). The aspects of hypertension associated with risk factors for atherosclerosis were analyzed, determining the risk of developing cardiovascular events in 10 years by FRS. From 432 families, 746 patients were selected, of which 340 are hypertensive individuals (SAH = 45.57%) and 406 (NSAH = 54.42%) non-hypertensives. Among the SAH the majority (31.17%) was in the age range of 63 - 77, but, in both groups, women were in stronger number. There was greater prevalence in SAH for all the characteristics analyzed, smoking (13.20%), sedentary (29.41%) and cardiovascular accident (22.60%). The SAH group is more susceptive to the CVD progress in 10 years by FRS (P